News
Global Cannabis News & Analysis | Business of Cannabis
News · page 9
- Medical Cannabis
Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?
The UK’s medical cannabis market has long been a locked box when it comes to reliable data.
- Interviews
From Land to Brand: Why Cannabis’s Next Generation Is Going Asset-Light
Last year (fiscal year 2024/2025), Canada’s legal cannabis industry recorded revenues of CA$5.5bn, according to the latest figures from Statistics Canada.
- Investment & Finance
Cannabis at an Inflexion Point: A Structural Repricing Ahead
Having spent over 30 years in advisory roles in financial markets prior to entering the cannabinoid industry, I lived through many hyperbolic boom/bust market cycles.
- US & Canada
Mounting Legal Challenges Threaten Hearing to Extend Cannabis Rescheduling to Adult Use
The critical June 29 administrative hearing, set to determine whether the US will extend rescheduling efforts to recreational cannabis, is now set to be a fiercely contested event.
- International Regulation
Stop Consulting, Start Implementing: South Africa’s Cannabis Industry Demands Action as Businesses Suffer
South Africa’s long-suffering cannabis operators have demanded that the government make good on its extensive plans for a regulated framework, as frustration with its lack of meaningful action reaches a boiling point.
- International Regulation
Australian State to End Automatic Licence Loss for Medical Cannabis Drivers
Australia’s New South Wales has moved to end the automatic penalisation of medicinal cannabis patients caught driving with THC in their system, introducing a registration and threshold-based framework that leaves most of Australia’s one million cannabis patients still without equivalent protection.
- Opinion
Europe’s Medical Cannabis Market Has Grown Up, Now Its Supply Chain Needs To
Written by Oskar Fletcher, Chief Executive of pharmaceutical contract manufacturing operator Blossom Pharma.
- CBD Market
Latest French CBD Crackdown To Be Challenged In Court
French trade groups are seeking to overturn the ban on the sale of CBD food supplements in an attempted re-run of the successful 2022 removal of the ban on the sale of flowers.
- UK & Europe
Germany’s Drug Commissioner Backs Cannabis Pilot Projects in Break With CDU Party Line
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the country’s booming cannabis industry has been bracing for a crackdown.
- Investment & Finance
Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity
For much of the past five years, the cannabis industry has been defined by disappointment.
- Medical Cannabis
Vertanical Secures Milestone FDA Breakthrough Designation for Cannabis Pain Drug Ahead of Imminent European Launch
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in prime position to become the first FDA-approved cannabis-derived medicine for pain, and only the second such approval since Epidiolex in 2018.
- Industry Trends
Cannabis Europa London 2026: Key Insights, Day 2
Live Cannabis Europa 2026 London, UK From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes Arjan Roskam, Green House Genetics; Dave Auger, Big League Genetics; Adele Hollman, Sanity Group; moderated by Alex Fraser, Grow Group Telemedicine in Germany: Maturity, Regulation and What Comes Next Kristine Lütke, 365 Sherpas GmbH; Dirk Heitepriem, German Cannabis…
